R P Perez - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

R P Perez

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996

Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicityN J Meropol, M Porter, L E Blumenson, et al.

International Journal of Radiation Oncology, Biology, Physics|August 3, 2001

Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreasJ M Pipas, S E Mitchell, R J Barth, et al.

Haemophilia : the Official Journal of the World Federation of Hemophilia|June 3, 2017

Episodic replacement of clotting factor concentrates does not prevent bleeding or musculoskeletal damage - the MUSFIH studyP Poonnoose, J D A Carneiro, A L Cruickshank, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996

Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicityN J Meropol, M Porter, L E Blumenson, et al.

International Journal of Radiation Oncology, Biology, Physics|August 3, 2001

Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreasJ M Pipas, S E Mitchell, R J Barth, et al.

Haemophilia : the Official Journal of the World Federation of Hemophilia|June 3, 2017

Episodic replacement of clotting factor concentrates does not prevent bleeding or musculoskeletal damage - the MUSFIH studyP Poonnoose, J D A Carneiro, A L Cruickshank, et al.

Pageof 4